Feldmann M - Search Results

1

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.

Feldmann M, Brennan FM, Williams RO, Woody JN, Maini RN. Feldmann M, et al. Best Pract Res Clin Rheumatol. 2004 Feb;18(1):59-80. doi: 10.1016/j.berh.2003.09.010. Best Pract Res Clin Rheumatol. 2004. PMID: 15123038 Review.

2

How does infliximab work in rheumatoid arthritis?

Maini RN, Feldmann M. Maini RN, et al. Among authors: feldmann m. Arthritis Res. 2002;4 Suppl 2(Suppl 2):S22-8. doi: 10.1186/ar549. Epub 2002 Mar 27. Arthritis Res. 2002. PMID: 12110154 Free PMC article. Review.

3

Cytokines and anti-cytokine biologicals in autoimmunity: present and future.

Andreakos ET, Foxwell BM, Brennan FM, Maini RN, Feldmann M. Andreakos ET, et al. Among authors: feldmann m. Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):299-313. doi: 10.1016/s1359-6101(02)00018-7. Cytokine Growth Factor Rev. 2002. PMID: 12220545 Review.

4

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Feldmann M, Maini RN. Feldmann M, et al. Nat Med. 2003 Oct;9(10):1245-50. doi: 10.1038/nm939. Nat Med. 2003. PMID: 14520364 No abstract available.

5

Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.

Foey AD, Field S, Ahmed S, Jain A, Feldmann M, Brennan FM, Williams R. Foey AD, et al. Among authors: feldmann m. Arthritis Res Ther. 2003;5(6):R317-28. doi: 10.1186/ar999. Epub 2003 Sep 3. Arthritis Res Ther. 2003. PMID: 14680506 Free PMC article.

6

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?

Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN. Feldmann M, et al. Novartis Found Symp. 2004;256:53-69; discussion 69-73, 106-11, 266-9. Novartis Found Symp. 2004. PMID: 15027483 Review.

7

A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis.

Campbell J, Ciesielski CJ, Hunt AE, Horwood NJ, Beech JT, Hayes LA, Denys A, Feldmann M, Brennan FM, Foxwell BM. Campbell J, et al. Among authors: feldmann m. J Immunol. 2004 Dec 1;173(11):6928-37. doi: 10.4049/jimmunol.173.11.6928. J Immunol. 2004. PMID: 15557189

8

Anti-TNF therapy: where have we got to in 2005?

Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN. Feldmann M, et al. J Autoimmun. 2005;25 Suppl:26-8. doi: 10.1016/j.jaut.2005.09.006. Epub 2005 Nov 2. J Autoimmun. 2005. PMID: 16260118 Review.

9

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.

Williams RO, Paleolog E, Feldmann M. Williams RO, et al. Among authors: feldmann m. Curr Opin Pharmacol. 2007 Aug;7(4):412-7. doi: 10.1016/j.coph.2007.06.001. Epub 2007 Jul 12. Curr Opin Pharmacol. 2007. PMID: 17627887 Review.

10

Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue.

Sacre SM, Drexler SK, Andreakos E, Feldmann M, Brennan FM, Foxwell BM. Sacre SM, et al. Among authors: feldmann m. Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii81-6. doi: 10.1136/ard.2007.079012. Ann Rheum Dis. 2007. PMID: 17934103 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

787 results

Search Page

Filters